Screener
Tango Therapeutics TNGX Cash Flow Statement
| Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | ||
|---|---|---|---|---|---|---|
| -$55.34M-42.4% | -$45.51M-14.1% | -$38.75M-2.9% | $15.88M+154% | -$38.85M-52.1% | ||
| $425K-32.0% | $463K-25.6% | $479K-22.7% | $555K-10.8% | $625K-1.1% | ||
| $16.89M+157% | $10.8M+48.8% | $5.98M-19.9% | $6.63M-7.7% | $6.57M-12.8% | ||
| -$38.87M-6.4% | -$44.36M-6.4% | -$29.72M+18.9% | -$30.95M+7.3% | -$36.52M-54.7% | ||
| -$20K-103% | -$2K-104% | $222K+79.0% | $151K+31.3% | $624K+95.0% | ||
| -$445.97M-2,758% | $9.64M-68.5% | -$135.72M-361% | $47.48M+45.8% | $16.78M+32.1% | ||
| $672.57M+115,661% | $79.85M+3,992,200% | $219.38M+22,539% | $2.54M+5.8% | $581K-55.7% | ||
| $187.73M+1,080% | $45.12M+507% | $53.94M+229% | $19.07M+1,105% | -$19.16M-99.6% | ||
| -$38.89M-4.7% | -$44.36M-6.3% | -$29.94M+18.6% | -$31.1M+7.2% | -$37.14M-55.2% |
FAQ
- How much cash does Tango Therapeutics generate?
- Tango Therapeutics (TNGX) generated -$143.9M in operating cash flow over the trailing twelve months.
- What is Tango Therapeutics's free cash flow?
- After $351.0K of capital expenditures, Tango Therapeutics's free cash flow was -$144.3M over the trailing twelve months, up 3.3% year over year.
- Where does Tango Therapeutics's cash flow data come from?
- Every line is extracted from Tango Therapeutics's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
